Background: Treatment for childhood cancer may increase the risk of long-term pulmonary complications and dysfunction. Pulmonary surveillance is recommended after established pulmonary toxic exposures, including bleomycin, busulfan, carmustine (BCNU), lomustine (CCNU), radiotherapy to a field exposing the lungs, and pulmonary surgery. However, the role of cyclophosphamide as a pulmonary toxic agent is debated.
View Article and Find Full Text PDFBackground: Because the occurrence of metabolic syndrome (MetS) might contribute to childhood cancer survivor's excess risk of cardiovascular disease, the authors assessed the prevalence and determinants of MetS in the Dutch Childhood Cancer Survivor Study (DCCSS-LATER2) cohort.
Methods: In total, 2338 adult childhood cancer survivors (CCS) were cross-sectionally assessed for the prevalence of MetS, using the Lifelines cohort (N = 132,226 adults without a history of cancer) as references. The prevalence of MetS was clinically assessed using existing classifications, as well as an alternative method using dual-energy x-ray absorptiometry fat% instead of waist circumference to define abdominal adiposity.
Cerebrovascular events (CVEs) are serious late adverse events among childhood cancer survivors. We estimated the incidence and risk factors of symptomatic CVEs and described the clinical characteristics among childhood cancer survivors after upper body radiotherapy. The Dutch Childhood Cancer Survivor Study LATER cohort study includes 5-year childhood cancer survivors diagnosed
Heavy metal (HM) contamination in agricultural crops, particularly vegetables, is a matter of global concern due to its potential health risks to humans. Commercially growing vegetable samples were analyzed for heavy metals using Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for leafy greens and fruit vegetables collected during winter from highly susceptible zones, in the vicinity of Kolkata. ICP-MS is advantageous over Atomic Absorption Spectrometry (AAS) for unparalleled accuracy, efficiency, faster turnaround time, cost-effectiveness, etc.
View Article and Find Full Text PDF